With 2026 less than 5 months away, the employer healthcare landscape is facing one of its most significant cost escalations in more than a decade. While employers have weathered cycles of benefit...

GLP‑1 medications such as Ozempic®, Wegovy®, and Zepbound®—originally developed to treat Type 2 diabetes—have rapidly become some of the most prescribed drugs for weight management. While their...

Attracting and retaining talent in 2025 requires more than compensation—it demands meaningful, sustainable benefits that address the real-world financial pressures employees face. Education-related...

As the business landscape evolves in 2025, employers are facing significant pressures related to Return to Office (RTO) mandates, especially from larger companies enforcing rigid work models. However...

In the first half of 2025, several pivotal developments involving the Mental Health Parity and Addiction Equity Act (MHPAEA) have emerged that carry significant implications for employers, including...

In an era where regulatory complexity and insurance innovation are evolving rapidly, a low-profile but potentially seismic shift is underway in Washington, D.C. In January 2025, Congress reintroduced...